Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 15, 2016
Total Value: $1.257B (99.6% shares, 0.4% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 16,658,072 | $112M | 8.9% | $6.75 | $4.81 | — | COM | 04269X105 |
| — | SEATTLE GENETICS INC | 1,781,470 | $96.22M | 7.7% | $54.01 | $41.29 | — | COM | 812578102 |
| FOLD | AMICUS THERAPEUTICS INC | 12,751,536 | $94.36M | 7.5% | $7.40 * | $7.13 | -5.3% | COM | 03152W109 |
| — | CLOVIS ONCOLOGY INC | 2,049,985 | $73.9M | 5.9% | $36.05 | $34.31 | — | COM | 189464100 |
| — | GW PHARMACEUTICALS PLC | 545,922 | $72.46M | 5.8% | $132.73 | $132.73 | — | ADS | 36197T103 |
| INCY | INCYTE CORP | 597,638 | $56.35M | 4.5% | $94.29 * | $92.56 | -9.0% | COM | 45337C102 |
| PEN | PENUMBRA INC | 672,918 | $51.13M | 4.1% | $75.99 * | $40.45 | +70.6% | COM | 70975L107 |
| MOH | MOLINA HEALTHCARE INC | 778,160 | $45.38M | 3.6% | $58.32 * | $55.76 | -1.2% | COM | 60855R100 |
| — | ENDOLOGIX INC | 3,480,644 | $44.55M | 3.5% | $12.80 | $10.30 | — | COM | 29266S106 |
| PBYI | PUMA BIOTECHNOLOGY INC | 662,286 | $44.41M | 3.5% | $67.05 * | $50.56 | 0.0% | COM | 74587V107 |
| — | ATARA BIOTHERAPEUTICS INC | 2,021,617 | $43.24M | 3.4% | $21.39 | $26.55 | — | COM | 046513107 |
| PRTA | PROTHENA CORP PLC | 701,659 | $42.08M | 3.3% | $59.97 * | $46.64 | +15.0% | SHS | G72800108 |
| SRPT | SAREPTA THERAPEUTICS INC | 640,400 | $39.33M | 3.1% | $61.41 * | $30.23 | 0.0% | COM | 803607100 |
| AGIO | AGIOS PHARMACEUTICALS INC | 737,900 | $38.98M | 3.1% | $52.82 * | $43.55 | 0.0% | COM | 00847X104 |
| CNC | CENTENE CORP DEL | 464,077 | $31.07M | 2.5% | $66.96 * | $33.66 | +3.2% | COM | 15135B101 |
| — | ARIAD PHARMACEUTICALS INC | 2,138,471 | $29.28M | 2.3% | $13.69 | $13.69 | — | COM | 04033A100 |
| BSX | BOSTON SCIENTIFIC CORP | 1,072,638 | $25.53M | 2.0% | $23.80 | $17.92 | +33.1% | COM | 101137107 |
| — | NANOSTRING TECHNOLOGIES INC | 1,237,435 | $24.72M | 2.0% | $19.98 | $13.81 | — | COM | 63009R109 |
| — | NEVRO CORP | 227,267 | $23.72M | 1.9% | $104.39 | $71.30 | — | COM | 64157F103 |
| — | OPHTHOTECH CORP | 505,154 | $23.3M | 1.9% | $46.13 | $46.13 | — | COM | 683745103 |
| — | ALDER BIOPHARMACEUTICALS INC | 702,539 | $23.02M | 1.8% | $32.77 | $32.77 | — | COM | 014339105 |
| WVE | WAVE LIFE SCIENCES LTD | 701,822 | $22.79M | 1.8% | $32.47 * | $15.65 | +51.0% | SHS | Y95308105 |
| — | PORTOLA PHARMACEUTICALS INC | 916,927 | $20.82M | 1.7% | $22.71 | $36.47 | — | COM | 737010108 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 1,431,119 | $17.98M | 1.4% | $12.56 | $13.93 | — | ORD SHS | G6855A103 |
| — | CHIMERIX INC | 3,214,946 | $17.81M | 1.4% | $5.54 | $3.93 | — | COM | 16934W106 |
| — | MODEL N INC | 1,550,959 | $17.23M | 1.4% | $11.11 | $10.67 | — | COM | 607525102 |
| — | AUDENTES THERAPEUTICS INC | 916,626 | $14.9M | 1.2% | $16.26 | $16.26 | — | COM | 05070R104 |
| — | NEURODERM LTD | 805,246 | $14.89M | 1.2% | $18.49 | $20.38 | — | ORD SHS | M74231107 |
| — | SYROS PHARMACEUTICALS INC | 892,782 | $11.74M | 0.9% | $13.15 | $15.91 | — | COM | 87184Q107 |
| CTMX | CYTOMX THERAPEUTICS INC | 714,692 | $11.21M | 0.9% | $15.68 * | $15.82 | -23.5% | COM | 23284F105 |
| CRL | CHARLES RIV LABS INTL INC | 127,106 | $10.59M | 0.8% | $83.34 | $73.82 | +13.6% | COM | 159864107 |
| AZN | ASTRAZENECA PLC | 288,356 | $9.475M | 0.8% | $32.86 | $32.86 | — | SPONSORED ADR | 046353108 |
| — | SPECTRANETICS CORP | 334,741 | $8.399M | 0.7% | $25.09 | $18.71 | — | COM | 84760C107 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 408,462 | $6.486M | 0.5% | $15.88 * | $9.44 | +23.9% | COM CL A | 46333X108 |
| — | VCA INC | 91,000 | $6.368M | 0.5% | $69.98 | $57.69 | — | COM | 918194101 |
| — | ALEXION PHARMACEUTICALS INC | 45,410 | $5.565M | 0.4% | $122.55 | $116.76 | — | COM | 015351109 |
| — | INTRA CELLULAR THERAPIES INC | 336,759 | $5.132M | 0.4% | $15.24 | $29.91 | — | COM | 46116X101 |
| — | ARRAY BIOPHARMA INC | 4,000,000 | $4.761M | 0.4% | $1.19 | $1.09 | — | NOTE 3.000% 6/0 | 04269XAA3 |
| — | INVITAE CORP | 510,369 | $4.471M | 0.4% | $8.76 | $9.07 | — | COM | 46185L103 |
| FATE | FATE THERAPEUTICS INC | 1,425,158 | $4.446M | 0.4% | $3.12 * | $5.74 | -57.8% | COM | 31189P102 |
| PRQR | PROQR THRAPEUTICS N V | 575,863 | $3.841M | 0.3% | $6.67 * | $15.63 | -64.8% | SHS EURO | N71542109 |
| — | BLUEPRINT MEDICINES CORP | 27,539 | $818K | 0.1% | $29.70 | $25.33 | — | COM | 09627Y109 |
| AUPH | AURINIA PHARMACEUTICALS INC | 187,610 | $565K | 0.0% | $3.01 * | $2.70 | +0.1% | COM | 05156V102 |
| FBT | FIRST TR EXCHANGE TRADED FD | 3,090 | $308K | 0.0% | $99.68 | $99.68 | — | NY ARCA BIOTECH | 33733E203 |
| UNH | UNITEDHEALTH GROUP INC | 1,820 | $255K | 0.0% | $140.11 * | $120.51 | 0.0% | COM | 91324P102 |
| HUM | HUMANA INC | 1,390 | $246K | 0.0% | $176.98 * | $160.64 | 0.0% | COM | 444859102 |
| DXCM | DEXCOM INC | 2,460 | $216K | 0.0% | $87.80 * | $22.24 | 0.0% | COM | 252131107 |
| BIIB | BIOGEN INC | 677 | $212K | 0.0% | $313.15 * | $263.54 | +12.4% | COM | 09062X103 |
| — | ACHAOGEN INC | 32,300 | $155K | 0.0% | $4.80 | $4.80 | — | COM | 004449104 |
| — | ADVERUM BIOTECHNOLOGIES INC | 22,236 | $91,000 | 0.0% | $4.09 | $3.15 | — | COM | 00773U108 |
| — | CASTLIGHT HEALTH INC | 10,229 | $43,000 | 0.0% | $4.20 | $4.01 | — | CL B | 14862Q100 |